Allos Therapeutics (ALTH) Reports Inline Q3 Loss Of $0.21

More News related to ALTH More News related to Earnings Allos Therapeutics, Inc. (NASDAQ: ALTH) reports Q3 loss of $0.21, inline with the analyst estimate of ($0.21). Related Categories Stocks Mentioned ALTH5.91 +0.17 +2.96% Volume: 1,799,753 Add Your Comment Verification can't see the text? click...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

UAE to aid Dubai on 'case by case' basis - Economictimes

Russia says bomb caused deadly train crash (Reuters) - Yahoo! News

City targets ex-NBA star for 'slum' housing: Walker 'humbly apologizes' for 'failings - Individual.com

Church of Scientology plans Illinois headquarters on Printer's Row: Opening of restored - Individual.com

Amanda Knox's Parents Reportedly Under Investigation - FOXNews.com

Featured Members

THENNY MEJIA
Sr. Vice President
Healthcare Industry

Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map